Table 1. Patient characteristics.

Characteristics	Desflurane	Sevoflurane	Propofol	P value
Number of patients	20	22	22
Age (years), mean ± SD	69.2±8.9	69.0±9.0	68.8±8.9	0.993
Male, n (%)	15 (75.0)	15 (68.2)	15 (68.2)	0.858
BMI, mean ± SD	22.5±2.8	22.8 ±4.2	24.5±3.6	0.149
ASA physical status, n (%)				0.625
1	0 (0.0)	2 (9.1)	2 (9.1)
2	14 (70.0)	16 (72.7)	14 (63.6)
3	6 (30.0)	4 (18.2)	6 (27.3)
WHO tumor stage, n (%)				0.48
0	3 (15.0)	2 (9.1)	1 (4.5)
I	9 (45.0)	12 (54.5)	17 (77.3)
II	4 (20.0)	5 (22.7)	1 (4.5)
III	3 (15.0)	1 (4.5)	2 (9.1)
Metastatic tumor	1 (5.0)	2 (9.1)	1 (4.5)
Surgical duration	148.0 [81.0–215.0]	155.0 [35.0–240.0]	146.5 [83.0–245.0]	0.984
Anesthetic duration	190.5 [128.0–282.0]	202.0 [73.0–295.0]	188.5 [119.0–304.0]	0.978
Duration of One lung ventilation	134.5 [54.0–206.0]	125.0 [27.0–220.0]	131.0 [70.0–224.0]	0.987
Hospital stay after surgery, day	5.0 [3.0–59.0]	6.0 [3.0–18.0]	5.0 [4.0–27.0]	0.293
Surgical procedure, n (%)
Lobectomy	14 (70.0)	16 (72.7)	19 (86.4)	0.449
Segment resection	2 (10.0)	4 (18.2)	2 (9.1)
Partial resection	4 (20.0)	2 (9.1)	1 (4.5)
Histological type, n (%)
Adenocarcinoma	16 (80.0)	15 (68.2)	14 (63.6)	0.551
Squamous cell carcinoma	3 (15.0)	3 (13.6)	7 (31.8)
Small cell carcinoma	0 (0.0)	1 (4.5)	0 (0.0)
Sarcoma	0 (0.0)	1 (4.5)	0 (0.0)
Metastatic tumor	1 (5.0)	2 (9.1)	1 (4.5)
Leukocyte (109/L)
Preoperative	6.20 [4.00–8.70]	5.10 [2.90–8.20]	5.85 [3.30–11.60]	0.029
Postoperative	6.75 [4.10–12.80]	4.85 [2.20–14.80]	5.80 [2.90–13.80]	0.048
Lymphocyte (%)
Preoperative	25.90 [11.80–46.60]	32.20 [16.50–46.20]	30.55 [15.30–44.40]	0.513
Postoperative	19.20 [10.30–38.30]	23.50 [7.00–44.70]	22.55 [6.70–38.60]	0.666

The data are presented as mean ± SD, median [range], or number (percentage). ASA, American Society of Anesthesiologists.